Trial Details

RECRUITING
Basic Information
Clinical ID c286
Identifier NCT06839820
Trial Title Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Infliximab|Infusion|IBD (Inflammatory Bowel Disease)|Patient Satisfaction
Interventions OTHER: Infusion rate of infliximab
Participant Information
Sponsor University Hospital, Akershus
City Lørenskog
Country/Region Norway
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2025-02-01
Primary Completion Date 2026-04
Completion Date 2026-04